Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains

Comparing risks and benefits of colorectal cancer screening in elderly patients.

Cynthia W Ko1, Amnon Sonnenberg

  • 1Department of Medicine, University of Washington, Seattle, 98195, USA. cwko@u.washington.edu

Gastroenterology
|October 19, 2005

Related Experiment Videos

View abstract on PubMed

Summary
This summary is machine-generated.

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Comparing Risks And Benefits Of Colorectal Cancer Screening In Elderly Patients.

    • Colorectal cancer screening benefits for elderly patients depend on age, health, and method. Risks can outweigh benefits for those with limited life expectancy, necessitating personalized screening decisions.

    Area of Science:

    • Geriatric Medicine
    • Preventive Oncology
    • Health Services Research

    Background:

    • Colorectal cancer screening risks may exceed benefits in patients with limited life expectancy.
    • This study quantifies risks and benefits of various screening strategies in elderly individuals with differing life expectancies.

    Discussion:

    • Screening benefits vary significantly with age, life expectancy, and modality (fecal occult blood tests, sigmoidoscopy, colonoscopy).
    • Colonoscopy offers the highest benefit but also carries the greatest risk of complications.
    • In some subgroups aged 70+, screening complications may outweigh benefits.

    Key Insights:

    • Preventing one cancer death requires screening different numbers of individuals based on age, sex, health, and method.
    • For instance, 42 healthy men aged 70-74 screened with colonoscopy vs. 945 men aged 80-84 with fecal occult blood tests.
    • While colonoscopy has higher risks, mortality reduction benefits generally outweigh colonoscopy-related death risks across all ages.

    Outlook:

    • Individualized assessment of screening risks versus benefits is crucial for elderly patients.
    • Screening decisions should prioritize likelihood of benefit, especially for those with shorter life expectancies.

    Related Experiment Videos